FIELD: food industry; pharmaceutics.
SUBSTANCE: invention relates to a method for producing amorphous water-soluble salts of magnesium citrate. The method consists in evaporating an aqueous solution of magnesium citrate MgC6H6O7 with a concentration of 40, wt. %, at temperatures up to 60°C, after the glass transition of the solution, the product is dried in air at a temperature of 40-60°C to a constant mass.
EFFECT: method makes it possible to obtain an amorphous water-soluble salt of magnesium citrate, which can be used as a part of food additives and other pharmacological preparations.
1 cl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABILISING COMPOSITION FOR DRY STORAGE OF BIOLOGIC MATERIALS (VERSIONS) | 2011 |
|
RU2573324C2 |
| AMORPHOUS WATER-SOLUBLE CALCIUM CITRATE SALTS AND ITS MANUFACTURING AND USAGE METHOD | 2005 |
|
RU2363269C2 |
| PHARMACEUTICAL COMPOSITION, METHODS FOR ITS PREPARING, STABLE WATER-INSOLUBLE COMPLEXES, METHOD FOR CONVERSION OF THERAPEUTICALLY ACTIVE COMPOUND AND THERAPEUTICALLY ACTIVE COMPOUND | 1999 |
|
RU2240827C2 |
| PHARMACEUTICAL DOSED FORM, CONTAINING POLYMER CARRIER COMPOSITION | 2009 |
|
RU2519679C9 |
| METHOD OF PRODUCING POLYMER ARTICLES WITH ANTIBACTERIAL PROPERTIES BASED ON SEMI-CRYSTALLINE POLYMERS | 2019 |
|
RU2717268C1 |
| MIGLUSTAT N-BUTYL-1,5-DIDEOXY-1,5-IMINO-D-GLUCITOL | 2019 |
|
RU2743694C1 |
| AMORPHOUS (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYLINDOL-1-YL)-ACETIC ACID | 2012 |
|
RU2616000C2 |
| CHARGE COMPOSITION FOR PRODUCING HEAT-INSULATING BLOCKS FROM NATURAL QUARTZ SAND | 2023 |
|
RU2817428C1 |
| 3-[2-(DIMETHYLAMINO)METHYL-(CYCLOHEX-1-YL)]PHENOL MALEATE AND ITS CRYSTALLINE FORMS | 2006 |
|
RU2434845C2 |
| SOLID DELIVERY SYSTEMS FOR CONTROLLED RELEASE OF INCLUDED MOLECULES AND METHOD FOR THEIR PREPARATION | 1995 |
|
RU2177785C2 |
